Services-General Medical & Surgical Hospitals, Nec
Surgery Partners, Inc. (SGRY) stock: what's happening now, every material event decoded in plain English, P/E and valuation, analyst ratings, and insider buying and selling.
AllSight quality score: 52/100 — a percentile rank of Surgery Partners, Inc.’s fundamentals against Services peers.
Is Surgery Partners, Inc. overvalued? P/S looks fair vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.
Consensus: Hold from 23 analysts (Buy 11 · Hold 12).
Average price target: $24.00 (−10.1% vs $26.69); range $24–$25.
Wall Street analyst consensus, shown as context — not an AllSight view.
Open-market buys: 2 · Open-market sells: 99 · Net: −$2.9B
Discretionary open-market purchases are the signal; grants, option exercises and Rule 10b5-1 scheduled trades are context, not counted in the balance. Facts only — not a recommendation. Source: SEC Form 4 filings on EDGAR.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!